Business Description
Lipum AB
ISIN : SE0015660899
Compare
Compare
Traded in other countries / regions
LIPUM.Sweden IPO Date
2021-04-22Description
Lipum AB is a clinical-stage biopharmaceutical company specializing in the discovery and development of a novel treatment for chronic inflammatory diseases. The candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule (BSSL) of the immune system. The development is supported by solid pre-clinical data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.84 | |||||
Equity-to-Asset | -1.36 | |||||
Debt-to-Equity | -0.37 | |||||
Debt-to-EBITDA | -0.09 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -2.1 | |||||
3-Year EPS without NRI Growth Rate | -2.1 | |||||
3-Year FCF Growth Rate | -4.3 | |||||
3-Year Book Growth Rate | -8.4 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.45 | |||||
9-Day RSI | 56.91 | |||||
14-Day RSI | 59.71 | |||||
6-1 Month Momentum % | 10.6 | |||||
12-1 Month Momentum % | -20.54 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.51 | |||||
Quick Ratio | 0.51 | |||||
Cash Ratio | 0.23 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -22.6 | |||||
Shareholder Yield % | -0.07 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -215.94 | |||||
ROA % | -119.8 | |||||
ROIC % | -1187.25 | |||||
ROC (Joel Greenblatt) % | -11755.97 | |||||
ROCE % | -179.72 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -9.61 | |||||
EV-to-EBITDA | -9.62 | |||||
EV-to-FCF | -10.86 | |||||
Earnings Yield (Greenblatt) % | -10.42 | |||||
FCF Yield % | -8.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lipum AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -2.003 | ||
Beta | 0 | ||
Volatility % | 55.97 | ||
14-Day RSI | 59.71 | ||
14-Day ATR (kr) | 0.575747 | ||
20-Day SMA (kr) | 8.1825 | ||
12-1 Month Momentum % | -20.54 | ||
52-Week Range (kr) | 5.5 - 14.441489 | ||
Shares Outstanding (Mil) | 21.21 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Lipum AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Lipum AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Lipum AB Frequently Asked Questions
What is Lipum AB(OSTO:LIPUM)'s stock price today?
The current price of OSTO:LIPUM is kr8.45. The 52 week high of OSTO:LIPUM is kr14.44 and 52 week low is kr5.50.
When is next earnings date of Lipum AB(OSTO:LIPUM)?
The next earnings date of Lipum AB(OSTO:LIPUM) is 2024-07-26.
Does Lipum AB(OSTO:LIPUM) pay dividends? If so, how much?
Lipum AB(OSTO:LIPUM) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |